EXPONENT INC
Exponent, Inc. (EXPO) reported Q2 2026 net revenues of $148.9 million, up 12% from $132.9 million a year earlier, and net income of $29.4 million, up 11%. Diluted EPS was $0.60. Management raised FY 2026 revenue guidance to 9% to 10% growth and EBITDA margin to 27.8% to 28.1%, and authorized an additional $50 million for share repurchases.
Exponent (NASDAQ:EXPO) reported Q2 EBITDA up 16% to $42.7 million, with EBITDA margin at 28.7% of net revenue versus 27.8% a year earlier. Billable hours rose 8% to about 390,000 and utilization increased to 74%. The company repurchased $67.4 million of stock and paid $14.8 million in dividends. It raised 2026 outlook for net revenue growth of 9% to 10%.
EXPONENT INC (EXPO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0000851520 0000851520 2026-06-04 2026-06-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
Over the past 7 days, alphai's AI scored 1 news story mentioning EXPO (EXPONENT INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent EXPO coverage spans financial news, earnings and corporate actions.
In the last 30 days, EXPO insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($109K). The most active reporter was Corrigan Catherine, Chief Executive Officer, with 1 filing. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
Raised FY and Q3 guidance plus higher EBITDA margin outlook, alongside active buybacks and higher utilization, point to improving operating leverage.
Raised full-year guidance plus higher Q2 profitability and utilization suggest improving demand and operating leverage, supporting a bullish near-term re-rating.
Routine corporate governance disclosures; limited direct fundamental change beyond confirming auditor and board composition.
Insider selling without a 10b5-1 plan can add near-term sentiment pressure, but the disclosed size is modest versus typical liquidity.
UBS's reduction of the price target for Exponent indicates cautious outlook despite strong earnings and dividend increases. The stock's current downtrend and insider selling suggest potential near-term weakness, but fundamentals remain solid.
alphai scores every news story that mentions EXPO with an AI model for sentiment and relevance, and aggregates insider trades from EXPONENT INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Exponent, Inc. (EXPO) reported Q2 2026 net revenues of $148.9 million, up 12% from $132.9 million a year earlier, and net income of $29.4 million, up 11%. Diluted EPS was $0.60. Management raised FY 2026 revenue guidance to 9% to 10% growth and EBITDA margin to 27.8% to 28.1%, and authorized an additional $50 million for share repurchases.
6 min readExponent (NASDAQ:EXPO) reported Q2 EBITDA up 16% to $42.7 million, with EBITDA margin at 28.7% of net revenue versus 27.8% a year earlier. Billable hours rose 8% to about 390,000 and utilization increased to 74%. The company repurchased $67.4 million of stock and paid $14.8 million in dividends. It raised 2026 outlook for net revenue growth of 9% to 10%.
6 min readEXPONENT INC (EXPO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0000851520 0000851520 2026-06-04 2026-06-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor
2 min readJames Bradley A (Group Vice President) sold 2,000 shares of EXPONENT INC (EXPO) at $57.46 ($0.11M total) on 2026-05-26.
1 min readUBS Group has reduced its price target for Exponent (NASDAQ:EXPO) from $85.00 to $75.00, maintaining a "neutral" rating on the stock. This adjustment comes despite Exponent reporting better-than-expected Q1 earnings with EPS of $0.59 and revenue of $166.3 million, and the company increasing its quarterly dividend and share buyback authorization. Insiders have been net sellers, and the stock is currently trading down, with a P/E ratio around 31.
4 min readExponent Inc. reported Q1 2026 earnings, with EPS of $0.57 exceeding forecasts and revenue of $144.47 million meeting expectations. The company's stock rose by 1.07% in aftermarket trading, reflecting strong performance driven by AI integration in consumer electronics and increased demand from energy and utility sectors. Exponent's CEO highlighted a strategic focus on innovation, while new President John Pye and CFO Eric Anderson were introduced, signaling a leadership evolution to capitalize on developing market trends.
4 min readJPMorgan Chase & Co. reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 24.7% in the third quarter, selling over 157,000 shares, though still holding 480,624 shares valued at $33.39 million. While other institutional investors made significant purchases, company insiders, including the CEO and a VP, sold a combined 9,583 shares. Exponent, which analysts rate a "Moderate Buy" with a $92.50 average target, recently beat earnings estimates and increased its quarterly dividend.
3 min readImage source: The Motley Fool.Thursday, October 30, 2025 at 4:30 p.m. ETPresident and Chief Executive Officer - Catherine Ford CorriganContinue reading ...
5 min readExponent (EXPO) delivered earnings and revenue surprises of +10.00% and +4.38%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2 min readOn October 24, 2025, Conestoga Capital Advisors, LLC disclosed in a new SEC filing that it sold 344,631 shares of Exponent ( NASDAQ:EXPO ) , an estimated trade valued at $24.63 million.According to a filing with the Securities and Exchange Commission dated October 24, 2025, Conestoga Capital ...
3 min read
